All Type of News
Opportunities and barriers in biosimilar market
Biopharmaceutical drugs (or biologics) have outperformed the pharmaceutical market as a whole largely due to two factors: they address areas of clinical need that are unmanageable with conventional therapeutics and th...
New drug-pricing plan aims to improve transparency in pharmaceutical industry
As a long-term plan to improve the transparency of the domestic pharmacy industry, the government plans to offer financial incentives to drug makers who invest more on research and development, said an official at the...
Government OKs sale of Novartis-produced MF59-adjuvanted flu vaccine
Korea’s health authorities gave the green light to Novartis Korea to sell MF59-adjuvanted influenza vaccine for elderly people aged 65 or more.
An adjuvant is an agent that enhances the immune system's response to ...
Korea has 3 million pensioners
The number of Korean pensioners exceeds 3 million as of September 28, since the introduction of national pension system in 1988.
The National Pension Corporation said 2 million people received the pension in Februa...
Avandia to be withdrawn from market
GlaxoSmithKline’s blockbuster anti-diabetic agent Avandia (rosiglitazone) will be banned from sales in the Korean market due to its possible cardiovascular risks.
The Korea Food and Drug Administration said on Sept...
GSK’s Avandia to be hit by near-blanket ban
The Korea Food and Drug Administration will deal a powerful blow to GlaxoSmithKline by issuing a near-blanket ban on sales of Avandia, the UK pharmaceutical group’s top-selling diabetes drug, according to market insid...
KFDA seeks to upgrade drug-related administration via GRP
The Korea Food and Drug Administration has recently revised 21 standard operating procedures (SOPs) of Good Review Practice (GRP) to ensure transparency in screening drug-related applications.
GRP is a “documented ...
Government to scrap new drug-pricing plan
The government plans to implement a new drug-pricing system aimed at uprooting rampant illegal rebate activities in the pharmaceutical industry.
Starting in October this year, the Ministry for Health, Welfare and ...
Development of local biodrugs to be promoted
The Korea Food and Drug Administration said on September 28 it has established a consultative review body to boost the development of new biodrugs.
The project, named “Dynamic BIO,” aims to develop a variety of new...
Government specifies illegal rebate activities in pharmaceutical sector
Starting this November, treating a doctor with a meal worth more than 100,000 won will be considered a rebate activity in the pharmaceutical industry.
The Ministry of Health and Welfare plans to enact a bill to leg...
